small-cell lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients who are histologically or cytologically diagnosed as small-cell lung cancer 2)Patients who diagnosed as limited disease 3) Patients treated with radical chemoradiotherapy 4) Patients without brain metastasis after radical chemoradiotherapy 5)Within 28 days after final chemotherapy or radiotherapy irradiation 6)PS 0 -2 7)Patients providing the written informed consent 8)Patients with life expectancy of at least 6 months
Exclusion criteria
Exclusion criteria: 1)Patients with less than or equal to 23 points of MMSE score 2)Any other patients who are regarded as unsuitable for this study by the principal investigator or sub-investigators. 3)Patients who refuse the participation in the study 4)Patients who did not respond to chemoradiation 5)Patients who cannot answer the questionnaire and MMSE 6)Patients treated with operation for LD-SCLC
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in MMSE score at 24 months from the enrollment | — |
Countries
Japan
Contacts
Kitasato University School of Medicine Department of Respiratory Medicine